Document and entity information

Dec 2021

Jun 2021

Company information

Company information

FASF member mark

true

2四半期決算短信

Document name

〔日本基準〕(連

結)

Filing date

2021-08-04

Company name

CREATE MEDIC

CO.,LTD.

Stock exchange listings

Tokyo

true

Tokyo 1st section

true

Tokyo 2nd section

-

Tokyo Mothers

-

Tokyo JASDAQ

-

Tokyo PRO Market

-

Tokyo Others

-

Nagoya

-

Nagoya 1st section

-

Nagoya 2nd section

-

Nagoya Centrex

-

Nagoya Others

-

Sapporo

-

Sapporo

-

Sapporo Ambitious

-

Sapporo Others

-

Fukuoka

-

Fukuoka

-

Fukuoka Q-Board

-

Fukuoka Others

-

Green Sheet

-

Japan Securities Dealers Association

-

Securities code

51870

URL

https://www.createm

edic.co.jp

Business category

General Business

true

Specific Business

-

Fiscal Year End

2021-12-31

Quarterly period

2

Representative

Title

代表取締役 社長

Name

佐藤 正浩

Inquiries

Title

執行役員 管理本部長

Name

今澤 修

Tel

045-943-2611

Other

Quarterly statement filing date (as planned)

2021-08-06

Dividend payable date (as planned)

2021-09-08

Supplemental material of quarterly results

true

Way of getting

-

Convening briefing of quarterly results

true

202185日に当

社ウェブサイトにて

Target for briefing of quarterly results

決算説明会の動画配

信を予定しておりま

す。)

Note to fraction processing method

(百万円未満切捨

て)

Business Results-Quarterly operating results

(in millions of yens)

Jun 2021

Jun 2020

Quarterly operating results

Quarterly operating results

Consolidated operating results

Consolidated income statements information

Net sales

Net sales

5,479

5,082

% change

7.8

-1.5

Operating profit

Operating profit

487

400

% change

21.6

-15.0

Ordinary profit

Ordinary profit

540

378

% change

42.9

-15.5

Profit attributable to owners of parent

Profit attributable to owners of parent

408

248

% change

64.6

-18.9

Note to consolidated income statements information

Comprehensive income

Comprehensive income

776

127

Change in comprehensive income

508.8

-34.4

Other consolidated operating results

Basic earnings per share (Yen)

44.91

26.64

Diluted earnings per share (Yen)

-

-

Note to consolidated operating results

Note to operating results

-

Business Results-Quarterly financial positions

(in millions of yens)

Jun 2021

Dec 2020

Quarterly financial positions

Quarterly financial positions

Consolidated financial positions

Total assets

17,926

17,097

Net assets

13,822

13,227

Capital adequacy ratio (%)

77.1

77.4

Net assets per share (Yen)

1,519.85

1,454.41

Note to consolidated financial positions

Owner'sequity

13,822

13,227

Note to financial positions

-

Business Results-Note to quarterly business results

Jun 2021

Quarterly note to business results

Quarterly note to business results

Note to consolidated financial results

Note to consolidated financial results

-

Quarterly Dividends

(in millions of yens)

Dec 2021

Jun 2021

Dec 2020

Quarterly dividends

Quarterly dividends

Dividends

Dividend per share (Yen)

Dividend per share (Yen)

First quarter

Result

-

-

Second quarter

Result

17.00

17.00

Third quarter

Result

-

Forecast

-

Upper

-

Lower

-

Year end

Result

20.00

Forecast

20.00

Upper

-

Lower

-

Annual

Result

37.00

Forecast

37.00

Upper

-

Lower

-

Correction of dividend forecast from the most recent dividend forecast

Correction of dividend forecast from the most recent dividend forecast

Annual

-

Note to dividends

Note to dividends

Annual

-

Quarterly Forecasts

(in millions of yens)

Dec 2021

Quarterly forecasts

Quarterly forecasts

3. 202112月期の連

Title for forecasts

結業績予想(2021

1 1日~202112

31日)

Preamble to consolidated forecasts

Preamble to forecasts

-

Main table of consolidated forecasts

Net sales

Net sales

Forecast

11,086

Upper

-

Lower

-

% change

Forecast

2.4

Upper

-

Lower

-

Operating profit

Operating profit

Forecast

788

Upper

-

Lower

-

% change

Forecast

-20.0

Upper

-

Lower

-

Ordinary profit

Ordinary profit

Forecast

800

Upper

-

Lower

-

% change

Forecast

-16.0

Upper

-

Lower

-

Profit attributable to owners of parent

Profit attributable to owners of parent

Forecast

559

Upper

-

Lower

-

% change

Forecast

-15.2

Upper

-

Lower

-

Basic earnings per share (Yen)

Basic earnings per share (Yen)

Forecast

61.46

Upper

-

Lower

-

Note to consolidated forecasts

Note to forecasts

-

Correction of financial forecast from the most recent financial forecast

Correction of financial forecast from the most recent financial forecast

Forecast

-

Notes, Quarterly-Material changes in subsidiaries during this period changes

in scope of consolidations resulting from change in subsidiaries

Jun 2021

Material changes in subsidiaries during this period (Changes in scope of consolidations resulting from change is subsidiaries)

Material changes in subsidiaries during this period (Changes in scope of consolidations resulting from change is subsidiaries)

Others

Material changes in subsidiaries during this period (Changes in scope of consolidations resulting from change is subsidiaries)

Material changes in subsidiaries during this period (Changes in

-

scope of consolidations resulting from change is subsidiaries)

Number of subsidiaries newly consolidated

-

Name of subsidiaries newly consolidated

-

Number of subsidiaries excluded from consolidation

-

Name of subsidiaries excluded from consolidation

-

Note to material changes in subsidiaries during this period

Note to material changes in subsidiaries during this period

-

Notes, Quarterly-Applying of specific accounting of the consolidated quarterly

financial statements

Jun 2021

Applying of specific accounting of the consolidated quarterly financial statements

Applying of specific accounting of the consolidated quarterly financial statements

Others

Applying of specific accounting of the consolidated quarterly financial statements

Applying of specific accounting of the consolidated quarterly

financial statements

-

Note to applying of specific accounting of the consolidated quarterly financial statements

Note to applying of specific accounting of the consolidated

quarterly financial statements

-

Notes, Quarterly-Changes in accounting policies and accounting estimates

retrospective restatement

Jun 2021

Changes in accounting policies, accounting estimates and retrospective restatement

Changes in accounting policies, accounting estimates and retrospective restatement

Others

Changes in accounting policies, accounting estimates and retrospective restatement

Changes in accounting policies based on revisions of accounting

-

standard

Changes in accounting policies other than ones based on

-

revisions of accounting standard

Changes in accounting estimates

-

Retrospective restatement

-

Note to changes in accounting policies, accounting estimates and

retrospective restatement

Note to changes in accounting policies, accounting estimates and

-

retrospective restatement

Notes, Quarterly-Number of issued and outstanding shares common stock

Jun 2021

Dec 2020

Jun 2020

Number of issued and outstanding shares (common stock)

Number of issued and outstanding shares (common stock)

Others

Number of issued and outstanding shares (common stock)

Number of issued and outstanding shares at the end of fiscal year

9,664,327

9,664,327

(including treasury stock)

Number of treasury stock at the end of fiscal year

569,348

569,284

Average number of shares

9,095,020

9,315,239

Note to number of issued and outstanding shares (common stock)

Note to number of issued and outstanding shares (common stock)

-

This information is a summary of the earnings report. It does not contain all details included in the earnings report disclosed in Japanese.

Attachments

  • Original document
  • Permalink

Disclaimer

CREATE MEDIC Co. Ltd. published this content on 04 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 August 2021 02:35:05 UTC.